Work

Identification of P450 Oxidoreductase as a Major Determinant of Sensitivity to Hypoxia-Activated Prodrugs

Year: 2015

Type: article

Source: Cancer Research

DOI: 10.1158/0008-5472.can-15-1107

Authors: Francis W. Hunter, Richard J. Young, Zvi Shalev, Ravi N. Vellanki, Jingli Wang, Yongchuan Gu, Naveen Joshi, Sreevalsan Sreebhavan, Ilan Weinreb, David P. Goldstein, Jason Moffat, Troy Ketela, Kevin R. Brown, Marianne Koritzinsky, Benjamin Solomon, Danny Rischin, William R. Wilson, Bradly G. Wouters

Institutions: University of Auckland, The University of Melbourne, Peter MacCallum Cancer Centre, University Health Network, Princess Margaret Cancer Centre, University of Toronto, Ontario Institute for Cancer Research

Language: English

Topic: Cancer, Hypoxia, and Metabolism

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Canadian Institutes of Health Research

Award: G1954209652

OpenAlex ID: W2118957304

FWCI: 2.59

Cites: 53

Cited by: 83

Related to: 10